Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kansas City Urology & Oncology (KCUC) is a leading multi-specialty medical group providing comprehensive urological and oncological care in the Kansas City metropolitan area. The organization operates as a vertically integrated provider, featuring an Advanced Prostate Cancer Center, a dedicated Radiation Oncology Center, and an in-house pathology laboratory. KCUC is a major participant in clinical research, maintaining a robust clinical trials department that focuses on Phase 2 and Phase 3 investigations for urologic malignancies. In 2020, the practice became a founding member of Solaris Health, a national platform for independent urological surgery practices. Their service offerings include robotic-assisted surgery, advanced imaging, and innovative systemic therapies for cancer management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kansas City Urology & Oncology.